Tepastim Injection 15 mg and 100 mg: Product Details and Uses

Tepastim Injection is an anticancer prescription medicine containing thiotepa, an alkylating agent used in specialist oncology treatment. It may be prescribed for certain cancers and as part of conditioning regimens before hematopoietic stem cell transplantation, depending on the patient's condition and the applicable product label.

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information and supports enquiries from international pharmaceutical buyers, distributors and healthcare organizations, subject to applicable regulatory requirements.

Tepastim Injection Product Details

Brand Name: Tepastim Injection

Active Ingredient: Thiotepa

Therapeutic Category: Antineoplastic / Alkylating Agent

Dosage Form: Injection

Administration: By qualified healthcare professionals

Prescription Status: Prescription medicine

Available Strengths: 15 mg and 100 mg presentations are listed in pharmaceutical product references.

Supply Enquiries: Cordium Pharmaceuticals Pvt Ltd

Product availability, manufacturer details, packaging, storage requirements and export eligibility should be confirmed against current product documentation before ordering.

Available Strengths of Tepastim Injection

Tepastim 15 mg Injection

Tepastim 15 mg Injection contains thiotepa and is used in specialist cancer treatment and selected transplantation protocols. The appropriate dose and treatment schedule depend on the indication, patient's clinical condition and oncology protocol.

Tepastim 100 mg Injection

Tepastim 100 mg Injection is a higher-strength presentation containing thiotepa. It may be considered within specialist treatment protocols where this presentation is appropriate. The prescribed dose must be calculated and administered by qualified medical professionals.

Important: These strengths are not interchangeable on a milligram-for-milligram vial basis without appropriate dose calculations and verification of the product's instructions.

Benefits and Therapeutic Uses of Tepastim Injection

1. Specialist Cancer Treatment

Thiotepa interferes with the DNA of rapidly dividing cells, helping prevent their growth and multiplication. Depending on the approved indication and treatment protocol, it may be used for certain breast, ovarian and bladder cancers.

2. Stem Cell Transplant Conditioning

Tepastim may be included in conditioning regimens before hematopoietic progenitor cell transplantation. The treatment aims to prepare the patient for transplantation and is selected according to the underlying disease and clinical plan.

3. Protocol-Based Oncology Care

When prescribed appropriately, thiotepa forms part of a specialist-led cancer treatment strategy. Its suitability and potential benefits must be evaluated against its risks by the treating oncology team.

Possible Side Effects and Safety Information

Tepastim Injection can cause serious adverse reactions. Reported effects associated with thiotepa include:

Reduced white blood cell, red blood cell and platelet counts

Increased risk of infection and bleeding

Nausea, vomiting and abdominal discomfort

Fatigue, weakness and loss of appetite

Skin reactions, rash or itching

Liver-related complications

Severe infection, unusual bleeding, allergic reactions or neurological symptoms require urgent medical assessment. Blood counts and organ function may need regular monitoring. Thiotepa can harm an unborn baby and may affect fertility. Patients should discuss pregnancy, breastfeeding and fertility preservation with their specialist before treatment.

This medicine must not be self-administered. Dosage, preparation, administration and storage must follow the current approved product information.

Frequently Asked Questions (FAQs)

1. What is Tepastim Injection used for?

Tepastim contains thiotepa and may be used for certain cancers and in selected stem cell transplantation conditioning regimens.

2. What strengths of Tepastim Injection are available?

Product references list Tepastim 15 mg and Tepastim 100 mg Injection. Confirm current availability and packaging with the supplier.

3. How does Tepastim Injection work?

Thiotepa damages the DNA of rapidly dividing cells, interfering with their ability to multiply.

4. Is Tepastim Injection a chemotherapy medicine?

Yes. Thiotepa is an alkylating chemotherapy agent used under specialist medical supervision.

5. How can international buyers enquire about Tepastim Injection?

Authorized pharmaceutical distributors and healthcare organizations can contact Cordium Pharmaceuticals Pvt Ltd to enquire about product documentation, availability and export requirements.

Contact Cordium Pharmaceuticals Pvt Ltd

For Tepastim Injection product information and pharmaceutical supply enquiries, contact Cordium Pharmaceuticals Pvt Ltd, India.